Detalles de la búsqueda
1.
A phase II study of gemcitabine, carboplatin, dexamethasone, and rituximab in patients with relapsed or refractory non-Hodgkin lymphoma.
Hematol Oncol
; 42(1): e3236, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37932900
2.
Single response assessment of transplant-ineligible multiple myeloma: a supplementary analysis of JCOG1105 (JCOG1105S1).
Jpn J Clin Oncol
; 51(7): 1059-1066, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33959770
3.
Comparison of breakthrough Gram-positive cocci infection during vancomycin vs teicoplanin therapy in patients receiving haematopoietic stem cell transplantation.
J Clin Pharm Ther
; 45(6): 1342-1348, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32656902
4.
[Acquired hemophilia A complicated by dipeptidyl peptidase-4 inhibitor-associated bullous pemphigoid].
Rinsho Ketsueki
; 61(5): 451-454, 2020.
Artículo
en Japonés
| MEDLINE | ID: mdl-32507807
5.
Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia.
Ann Hematol
; 98(2): 351-359, 2019 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-30341537
6.
A case of acute promyelocytic leukemia with pericardial effusion successfully managed with colchicine during ATO administration.
Ann Hematol
; 103(4): 1409-1410, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38376572
7.
[Thrombotic thrombocytopenic purpura during pregnancy refractory to plasma exchange and rituximab].
Rinsho Ketsueki
; 60(3): 209-212, 2019.
Artículo
en Japonés
| MEDLINE | ID: mdl-31068517
8.
R-THP-COP versus R-CHOP in patients younger than 70 years with untreated diffuse large B cell lymphoma: A randomized, open-label, noninferiority phase 3 trial.
Hematol Oncol
; 36(4): 638-644, 2018 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-29882279
9.
A salvage chemotherapy of R-P-IMVP16/CBDCA consisting of rituximab, methylprednisolone, ifosfamide, methotrexate, etoposide, and carboplatin for patients with diffuse large B cell lymphoma who had previously received R-CHOP therapy as first-line chemotherapy.
Hematol Oncol
; 35(3): 288-295, 2017 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-26999778
10.
Serum concentrations of l-kynurenine predict clinical outcomes of patients with peripheral T-cell lymphoma, not otherwise specified.
Hematol Oncol
; 35(4): 637-644, 2017 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-27338762
11.
CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin.
Hematol Oncol
; 35(2): 163-171, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-26449182
12.
Time-Series Modeling and Simulation for Comparative Cost-Effective Analysis in Cancer Chemotherapy: An Application to Platinum-Based Regimens for Advanced Non-small Cell Lung Cancer.
Biol Pharm Bull
; 40(1): 73-81, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28049952
13.
Control of Constipation in Patients Receiving CHOP or CHOP-Like Chemotherapy Regimens for Non-Hodgkin's Lymphoma.
Biol Pharm Bull
; 40(5): 698-702, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28458356
14.
Preventive Effects of Pentoxifylline on the Development of Colonic Premalignant Lesions in Obese and Diabetic Mice.
Int J Mol Sci
; 18(2)2017 Feb 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-28212276
15.
Efficacy and safety of denosumab in multiple myeloma.
Rinsho Ketsueki
; 57(5): 592-6, 2016 05.
Artículo
en Japonés
| MEDLINE | ID: mdl-27263783
16.
Sarcopenia is an independent prognostic factor in male patients with diffuse large B-cell lymphoma.
Ann Hematol
; 94(12): 2043-53, 2015 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-26385388
17.
Multiple myeloma with IGH-FGFR3 rearrangement progressing as testicular plasmacytoma during carfilzomib treatment.
Ann Hematol
; 98(10): 2463-2465, 2019 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240468
18.
Impact of Skeletal Muscle Depletion on Patients with Myelodysplastic Syndrome Treated with Azacitidine.
Hematol Rep
; 16(1): 114-124, 2024 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38534882
19.
The pretreatment Controlling Nutritional Status score is an independent prognostic factor in elderly patients with diffuse large B-cell lymphoma.
Leuk Lymphoma
; 65(3): 339-345, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38124378
20.
Serum level of soluble tumor necrosis factor receptor 2 is associated with the outcome of patients with diffuse large B-cell lymphoma treated with the R-CHOP regimen.
Eur J Haematol
; 91(4): 322-31, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-23672298